Professor Leedman is an internationally recognised physician scientist who combines academic translational cancer research and teaching, with running the Harry Perkins Institute of Medical Research and clinical endocrinology. His research has led to several key discoveries on hormone action in cancer as well as patents and company development (MiReven). He has had many senior leadership roles in H&MR, including senior NHMRC activities, Advisory Committees and Chairman of companies, such as Linear Clinical Trials Ltd. He has been recognised with awards from the Australian & UK Endocrine Societies and the WA Government for Innovator of the Year in 2013 for MiReven.
